Customer Reviews
Product Description
iReju-PN β Anti-Aging and Skin Regenerating Injectable
Description:
iReju-PN is a professional-grade injectable designed to restore, brighten, and rejuvenate the skin. Formulated with sodium polynucleotide (PN), it effectively improves skin elasticity, tone, and dermal density while helping repair the skin barrier. PN is a cutting-edge biocompatible substance developed through DNA Optimization Technology (DOT), offering more potent regenerative effects than PDRN. This treatment is trusted by professionals to address aging skin, fine lines, enlarged pores, and skin damage.
Key Benefits:
– Improves skin elasticity and firmness.
– Restores skin brightness and evens out skin tone.
– Strengthens the skin barrier and increases dermal thickness.
– Smoothes rough skin texture and reduces fine lines.
– Helps heal scars, enlarged pores, and damaged skin.
– Supports tissue regeneration, benefiting ligaments and tendons.
Main Ingredients:
– Sodium Polynucleotide (PN) 2 mg/ml.
– Phosphate-buffered saline, pH 7.
Specifications:
– 1 ml pre-filled syringe.
– Shelf life: 3 years.
– Storage: Room temperature.
How to Use:
– For professional use only.
– Administered by a licensed aesthetic practitioner.
– Suitable for mesotherapy, microneedling, or injection techniques.
Why Choose iReju-PN:
– Advanced PN formula with enhanced regenerative effects compared to PDRN.
– Promotes deep skin repair and long-term anti-aging results.
– Supports overall skin health and tissue regeneration.
Disclaimers and Safety:
– For professional use only β consult a licensed medical professional.
– External injection only β not for self-use.
– Store in a cool, dry place at room temperature.
– Keep out of reach of children.
– Not intended to diagnose, treat, cure, or prevent any disease.
– Results may vary based on individual skin condition.
Revitalize Your Skin with iReju-PN β Restore Youthful Radiance Today.
Related Products
Discover timeless elegance and luxurious beauty crafted just for you.
Reviews
There are no reviews yet